Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients-Reference-Cited by-同舟云学术

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

Published:2012-09-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Katz Lior H¹,Goldvaser Hadar²,Gafter-Gvili Anat³,Tur-Kaspa Ran⁴

Affiliation:

1. MD Anderdson Cancer Center; Hepatology and Nutrition Department; 1515 Holcombe st. Houston Texas USA 77030

2. Beilinson Hospital, Rabin Medical Center; Department of Oncology; Petah Tikva Israel

3. Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100

4. Beilinson Hospital, Rabin Medical Center; Department of Medicine D; 39 Jabotinski Street Petah Tikva Israel 49100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008516.pub2/fullpdf

Reference67 articles.

1. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin;Berg;Gastroenterology,2006

2. Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with HCV genotype 1 and slow virologic response;Buti;Hepatology,2010

3. Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3;Lee;Alimentary Pharmacolology and Therapuetics,2012

4. Liu C-H Liang C-C Liu C-J Lin C-L Yang S-S Hsu S-J Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks for patients with chronic hepatitis C virus genotype 1 infection having shown slow antiviral response Hepatology International 2011

5. Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial;Mangia;Hepatology,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C;World Journal of Gastroenterology;2023-02-14

2. Interventions for the management of fatigue in adults with a primary brain tumour;Cochrane Database of Systematic Reviews;2022-09-12

3. Management of Hepatitis C in Children and Adolescents;Journal of the Pediatric Infectious Diseases Society;2020-10-12

4. Interventions for the management of fatigue in adults with a primary brain tumour;Cochrane Database of Systematic Reviews;2016-04-13

5. Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2015-04-14